Alignment Healthcare (ALHC) Scheduled to Post Earnings on Thursday

Alignment Healthcare (NASDAQ:ALHC) is scheduled to post its quarterly earnings results after the market closes on Thursday, May 2nd. Analysts expect Alignment Healthcare to post earnings of ($0.24) per share for the quarter. Alignment Healthcare has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings results on Tuesday, February 27th. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.03). Alignment Healthcare had a negative return on equity of 75.64% and a negative net margin of 8.12%. The firm had revenue of $465.39 million for the quarter, compared to analyst estimates of $444.56 million. During the same period in the prior year, the firm posted ($0.31) EPS. The business’s revenue was up 28.6% compared to the same quarter last year. On average, analysts expect Alignment Healthcare to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Alignment Healthcare Stock Performance

Shares of ALHC opened at $5.18 on Thursday. The stock has a 50-day moving average of $5.28 and a two-hundred day moving average of $6.62. Alignment Healthcare has a one year low of $4.46 and a one year high of $9.20. The company has a debt-to-equity ratio of 1.02, a quick ratio of 1.84 and a current ratio of 1.84. The stock has a market cap of $978.92 million, a P/E ratio of -6.56 and a beta of 1.30.

Analyst Upgrades and Downgrades

ALHC has been the subject of a number of research reports. UBS Group lowered their price target on Alignment Healthcare from $9.00 to $8.50 and set a “neutral” rating for the company in a research report on Wednesday, February 28th. Stephens lifted their price target on Alignment Healthcare from $10.00 to $10.50 and gave the stock an “equal weight” rating in a research report on Tuesday, January 9th. William Blair reiterated an “outperform” rating on shares of Alignment Healthcare in a research note on Wednesday, March 6th. Barclays started coverage on Alignment Healthcare in a research note on Wednesday, March 6th. They set an “underweight” rating and a $4.50 price objective for the company. Finally, Raymond James lifted their price objective on Alignment Healthcare from $10.00 to $12.00 and gave the company a “strong-buy” rating in a research note on Tuesday, January 9th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Alignment Healthcare presently has an average rating of “Hold” and an average target price of $9.18.

Insider Activity at Alignment Healthcare

In related news, insider Dawn Christine Maroney sold 23,000 shares of Alignment Healthcare stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $5.44, for a total value of $125,120.00. Following the completion of the transaction, the insider now owns 1,830,008 shares in the company, valued at approximately $9,955,243.52. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, CFO Robert Thomas Freeman sold 11,858 shares of Alignment Healthcare stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $4.89, for a total value of $57,985.62. Following the sale, the chief financial officer now directly owns 898,228 shares in the company, valued at approximately $4,392,334.92. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Dawn Christine Maroney sold 23,000 shares of Alignment Healthcare stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $5.44, for a total value of $125,120.00. Following the completion of the sale, the insider now owns 1,830,008 shares in the company, valued at $9,955,243.52. The disclosure for this sale can be found here. Insiders sold a total of 90,213 shares of company stock worth $460,587 in the last 90 days. Corporate insiders own 6.30% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.